Guanwei Fan | Component-Based TCM | Best Researcher Award

Dr. Guanwei Fan 🧑‍🔬, Vice President of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 🏥, is a leading researcher in cardiovascular pharmacology using Traditional Chinese Medicine (TCM) 💊❤️. As Director of the Tianjin Key Laboratory of TCM Prescription and Syndrome Transformation and Principal Investigator at the National Key Lab of Component-based TCM, he has led over 20 major national and international research projects 🌏📊. Recognized globally 🌟, he ranks in the top 2% of scientists worldwide and contributes significantly to TCM innovation, publishing over 160 papers and securing 25 patents 📚🧪.

Publication Profiles

Scopus

 Education & Experience 

• 🎓 Ph.D. in Traditional Chinese Medicine – Specialized in cardiovascular disease prevention and treatment

• 🏥 Vice President, First Teaching Hospital of Tianjin University of TCM

• 🧪 Director, Tianjin Key Laboratory of TCM Prescription and Syndrome Transformation

• 🧬 Principal Investigator, National Key Laboratory of Component-based TCM (Cardiovascular Pharmacology Innovation Team)

• 🌐 Participated in over 20 national and international research collaborations including 973 & Key R&D programs

• 🧾 Filed 25 invention patents (10 granted), with 4 transferred to industry

• 📝 Published 160+ peer-reviewed papers; H-index: 43

Suitability for the Award

Dr. Guanwei Fan is an exemplary candidate for the Best Researcher Award, recognized for his transformative contributions to the field of Traditional Chinese Medicine (TCM), particularly in the prevention and treatment of cardiovascular diseases. As Vice President of the First Teaching Hospital of Tianjin University of TCM, Director of the Tianjin Key Laboratory of TCM Prescription and Syndrome Transformation, and Principal Investigator of the National Key Laboratory of Component-based TCM—Cardiovascular Pharmacology Innovation Team, Dr. Fan leads multidisciplinary efforts that bridge traditional medicine with modern pharmacology.

 Professional Development

Dr. Guanwei Fan’s career exemplifies leadership in integrating traditional Chinese medical theory with modern pharmacology 🧠💡. As a principal investigator and lab director, he continuously mentors researchers and leads cutting-edge projects focused on cardiovascular therapeutics through TCM 🔬❤️. His commitment to translational medicine bridges research and real-world application, demonstrated by multiple patent transfers to industry 🏭📈. Dr. Fan’s inclusion in the national “Ten Thousand Talents Program” and other elite scientific tracks marks him as a vital force in China’s health innovation ecosystem 🇨🇳🌟. His work fosters international cooperation, further cementing his role as a global TCM ambassador 🌐🌿.

 Research Focus 

Dr. Guanwei Fan’s research centers on cardiovascular disease prevention and treatment through the lens of Traditional Chinese Medicine (TCM) ❤️🌿. His work emphasizes component-based TCM, investigating multi-target pharmacology and syndrome transformation 🔍💊. By leveraging modern biomedical techniques alongside traditional principles, he aims to decode TCM formulations and validate their efficacy through empirical science 🧪📊. His team contributes to innovative drug development, targeting complex mechanisms in heart-related illnesses 🫀🧬. This integrative approach not only enhances the credibility of TCM globally 🌍📚 but also advances precision medicine with a holistic health perspective 🧘‍♂️🔬.

 Awards & Honors 

• 🏅 Selected for the national “Ten Thousand Talents Program”

• 💼 State Council Special Government Allowance recipient

• 🧑‍🔬 MOST Leading Talent in Scientific and Technological Innovation

• 🌱 First Young Qi Huang Scholar

• 🌟 First Tianjin Outstanding Young Scholar

• 👨‍⚕️ First Tianjin Medical Talent

• 🏆 Youth Expert with Outstanding Contributions, Ministry of Human Resources

• 🌍 Ranked in Top 2% of Global Scientists (2022–2024)

• 🥇 1 First-Class and 🥈 3 Second-Class Science & Technology Progress Awards

• 🧠 Nominated for National Top 100 Excellent Doctoral Theses

• 🎖️ Received Tianjin Excellent Doctoral Thesis Award

Publication Top Noted

• Lingguizhugan decoction inhibits pulmonary hypertension via IL-33/ST2-regulated macrophage IL-6 secretion (Phytomedicine, 2025) 🫁🧬

• Meta-analysis on Shenmai Injection for coronary heart disease and heart failure (Drug Evaluation Research, 2025) ❤️📊

• Th17 Cells in Cardiovascular Disease – Review (2025) 🧠🫀

• Role of macrophages in cardiac arrhythmias: pathogenesis and therapeutic perspectives – Review (2025) ⚡🧫

• Borneolum syntheticum metabolites reduce atherosclerosis by inhibiting macrophage foam-cell formation (Acta Pharmacologica Sinica, 2025) 🧪🩸

• Topical treatment of allergic contact dermatitis with Portulacae Herba via Nrf2/HO-1/NF-κB pathway (Chinese Journal of Experimental Traditional Medical Formulae, 2025) 🌿🧴

• Screening Uncaria-based natural inhibitors for Alzheimer’s using near-infrared fluorescence probe (Sensors and Actuators B: Chemical, 2025) 🧠💡

• Isoprenaline induces cardiac hypertrophy by inhibiting LSD1 (Cardiovascular Toxicology, 2025) 💊❤️‍🔥